BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9790252)

  • 1. Changes in levels of serum and urinary collagen-related substances in growth hormone deficient children following discontinuation of growth hormone therapy.
    Kuno T; Miyazaki S
    Endocr J; 1998 Apr; 45 Suppl():S151-3. PubMed ID: 9790252
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of growth hormone (GH) replacement on plasma carboxy-terminal propeptide of type I procollagen (PICP) and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) levels in GH-deficient adult patients.
    Murakami Y; Sugitani M; Koshimura K; Sohmiya M; Kato Y
    Endocr J; 1998 Apr; 45 Suppl():S121-4. PubMed ID: 9790245
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone substitution in growth hormone-deficient adults: effects on collagen type I synthesis and skin thickness.
    Kann P; Piepkorn B; Schehler B; Lotz J; Prellwitz W; Beyer J
    Exp Clin Endocrinol Diabetes; 1996; 104(4):327-33. PubMed ID: 8886750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coeliac children treated for growth hormone deficiency reach normal final height.
    Meazza C; Pagani S; Messini B; Cardinale GM; Mastrangelo C; Citro G; Delvecchio M; Tinelli C; Corazza GR; Bozzola M
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):791-2. PubMed ID: 21166689
    [No Abstract]   [Full Text] [Related]  

  • 6. Collagen formation and degradation increase during growth hormone therapy in children.
    Vihervuori E; Turpeinen M; Siimes MA; Koistinen H; Sorva R
    Bone; 1997 Feb; 20(2):133-8. PubMed ID: 9028537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disorders.
    Juul A; Bernasconi S; Chatelain P; Hindmarsh P; Hochberg Z; Hokken-Koelega A; de Muinck Keizer-Schrama SM; Kiess W; Oberfield S; Parks J; Strasburger CJ; Volta C; Westphal O; Skakkebaek NE
    Horm Res; 1999 Dec; 51(6):284-99. PubMed ID: 10640890
    [No Abstract]   [Full Text] [Related]  

  • 9. [The model of height prognosis in children with growth hormone deficiency].
    Kostecka L; Wasikowa R; Noczyńska A; Filipowski H
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):113-7. PubMed ID: 15504314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalised acanthosis nigricans in childhood with short stature associated with poor response to growth hormone provocation.
    Iwade M; Ogawa E; Koga H; Mizuno F; Koike K; Matsumoto K; Okuyama R
    Acta Derm Venereol; 2014 Jul; 94(4):486-7. PubMed ID: 24285118
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of growth hormone therapy on bone metabolism of growth hormone deficient children.
    Stamoyannou L; Karachaliou F; Gioureli E; Voskaki E; Mengreli C; Bartsocas CS; Koutselinis A
    Eur J Pediatr; 1997 Aug; 156(8):592-6. PubMed ID: 9266187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen metabolites in the prediction of response to GH therapy in short children.
    Tapanainen P; Knip M; Risteli L; Kemppainen L; Käär ML; Risteli J
    Eur J Endocrinol; 1997 Dec; 137(6):621-5. PubMed ID: 9437226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors determining growth response in recombinant growth hormone treatment of growth hormone deficient children].
    Pan SN; Du ML; Chen HS
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):544-5. PubMed ID: 17044985
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.
    Wan L; Chen WC; Tsai Y; Kao YT; Hsieh YY; Lee CC; Tsai CH; Chen CP; Tsai FJ
    Pediatr Res; 2007 Dec; 62(6):735-40. PubMed ID: 17957148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Homocysteine levels in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):87-92. PubMed ID: 15504311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency.
    Juul A; Bernasconi S; Clayton PE; Kiess W; DeMuinck-Keizer Schrama S;
    Horm Res; 2002; 58(5):233-41. PubMed ID: 12401943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone therapy in children in Canada: what have we learned in the past decade from an unlimited supply of growth hormone?
    Dean H
    Clin Invest Med; 1999 Apr; 22(2):60-2. PubMed ID: 10340105
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone resistance and new aspects of GH therapy. Proceedings of the 2nd Workshop on Clinical Paediatric Endocrinology. Salzburg, Austria, September 7-8, 1998.
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():229-353. PubMed ID: 10722306
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of short- and long-acting recombinant human growth hormone (PEG-rhGH) on left ventricular function in children with growth hormone deficiency.
    Wang CL; He Y; Liang L; Zou CC; Hong F; Dong GP; Pei J
    Acta Paediatr; 2011 Jan; 100(1):140-2. PubMed ID: 20735363
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.